Results 121 to 130 of about 99,906 (258)
Antibiofilm assay for antimicrobial peptides combating the sulfate-reducing bacteria Desulfovibrio vulgaris. [PDF]
Stillger L +3 more
europepmc +1 more source
Genome‐wide CRISPRi and RNA‐seq resolve how B. thetaiotaomicron converts host mucosal glycans into fitness. The study reveals a layered mucin‐utilization architecture in which capsular polysaccharides constrain surface access, extracellular CAZymes and peptidases show functional redundancy, and intracellular catabolic pathways create discrete metabolic
Kangsan Kim +5 more
wiley +1 more source
The Sulfate-Reducing Bacteria Hypothesis in Parkinson's Disease: From <i>Desulfovibrio</i>-Derived Hydrogen Sulfide to Alpha-Synuclein Aggregation. [PDF]
Koterba M +6 more
europepmc +1 more source
Fluorinated β‐glucan/pectin nanogels enable colon‐targeted oral delivery of astilbin through gastrointestinal protection, β‐glucanase‐responsive release, mucus penetration, and prolonged retention. The released astilbin attenuates senescence‐associated features of CD4+ T cells and promotes Treg responses, while the nanogel matrix modulates the gut ...
Lei Zhao +11 more
wiley +1 more source
Exploratory Assessment of Iron- and Sulfate-Reducing Bacteria in Sediments Co-Contaminated with Metals and Polycyclic Aromatic Hydrocarbons. [PDF]
Johnston GP, Lisko DJ, Johnston CG.
europepmc +1 more source
Inorganic PbS quantum dots spatially confine AIEgens and enable cooperative luminescence within a ligand‐directed core–shell–shell nanoassembly, generating ultrabright NIR PPANPs with enhanced fluorescence and photothermal performance. The platform enables 10‐min S.
Yujian Li +15 more
wiley +1 more source
Symbiosis reshapes metabolism of sulfate-reducing bacteria in gutless marine worms. [PDF]
D'Angelo G +9 more
europepmc +1 more source
NADH and NADPH peroxidases as antioxidant defense mechanisms in intestinal sulfate-reducing bacteria. [PDF]
Kushkevych I +6 more
europepmc +1 more source
Lipid mesophases provide a versatile platform for colon‐targeted delivery of biotherapeutics, protecting them from degradation while enhancing mucoadhesion and enabling localized, controlled release to the inflamed mucosa after oral or rectal administration. In a DSS‐induced colitis model, this strategy reduced disease activity, inflammatory biomarkers,
Rafaela Gazzi +13 more
wiley +1 more source
Classification of the spore-forming sulfate-reducing bacteria [PDF]
L L, Campbell, J R, Postgate
openaire +2 more sources

